Dr Lal PathLabs reported a strong financial performance for the second quarter, with net profit rising by 18.9 per cent year-on-year (YoY) to Rs 130.8 crore, up from Rs 110 crore in the same period last year. The company's revenue saw a healthy increase of 9.8 per cent, reaching Rs 660.2 crore compared to Rs 601.3 crore YoY, driven by higher diagnostic volumes.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The company’s EBITDA also grew by 13.9%, totalling Rs 202.5 cr, while the EBITDA margin improved to 30.7% from 29.6% YoY.

This solid performance reflects efficient cost management and enhanced operational efficiency during the quarter.